PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF VERINURAD (RDEA3170), A SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN HEALTHY ADULT MALE SUBJECTS

被引：0
|
作者：
Gillen, M. [1 ]
Shen, Z. [2 ]
Miner, J. N. [2 ]
机构：
[1] AstraZeneca, Gaithersburg, MD USA
[2] Ardea Biosci Inc, San Diego, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.5133
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0886
引用
收藏
页码：1366 / 1366
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects
    Ulf G. Eriksson
    Ulf Bredberg
    Kristina Gislén
    Linda C. Johansson
    Lars Frison
    Martin Ahnoff
    David Gustafsson
    European Journal of Clinical Pharmacology, 2003, 59 : 35 - 43
  • [42] Pharmacokinetics, Pharmacodynamics and Safety of a Single Dose of Imarikiren, a Novel Renin Inhibitor, in Healthy Male Subjects
    Matsuno, Kumi
    Kuroda, Shingo
    Tanaka, Shingo
    Nakamichi, Hiroyuki
    Kagawa, Tomoya
    Koumura, Emiko
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (05) : 607 - 614
  • [43] Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects
    Eriksson, UG
    Bredberg, U
    Gislén, K
    Johansson, LC
    Frison, L
    Ahnoff, M
    Gustafsson, D
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (01) : 35 - 43
  • [44] Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects
    Jane Knöchel
    Karin Nelander
    Maria Heijer
    Eva-Lotte Lindstedt
    Gun-Britt Forsberg
    Carl Whatling
    Hitoshi Shimada
    David S. Han
    Anders Gabrielsen
    Pavlo Garkaviy
    Hans Ericsson
    Clinical Drug Investigation, 2021, 41 : 895 - 905
  • [45] Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects
    Knochel, Jane
    Nelander, Karin
    Heijer, Maria
    Lindstedt, Eva-Lotte
    Forsberg, Gun-Britt
    Whatling, Carl
    Shimada, Hitoshi
    Han, David S.
    Gabrielsen, Anders
    Garkaviy, Pavlo
    Ericsson, Hans
    CLINICAL DRUG INVESTIGATION, 2021, 41 (10) : 895 - 905
  • [46] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Compound SFDAC by Intranasal Administration of Multiple Escalating Dose in Healthy Male Subjects
    Thennati, Rajamannar
    Khanna, Aman
    Khanna, Mallika
    Sonaiya, Tushar
    Mehta, Tejas
    Mehta, Kalpana
    Shahi, Pradeep
    Patel, Jigneshkumar
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (06): : 428 - 438
  • [47] Pharmacokinetics, pharmacodynamics, and tolerability of single rising doses of the dipeptidyl peptidase-IV inhibitor alogliptin benzoate (SYR-322) in healthy male subjects
    Christopher, Ronald
    Covington, Paul
    Davenport, Michael
    Fleck, Penny
    Mekki, Qais
    Wann, Elisabeth
    Karim, Aziz
    DIABETES, 2007, 56 : A132 - A132
  • [48] Clinical Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Darexaban, an Oral Direct Factor Xa Inhibitor, in Healthy Elderly Japanese Subjects
    Kadokura, Takeshi
    Oikawa, Keishi
    Miyata, Koji
    Murase, Toshinobu
    Nakamura, Mashio
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (04): : 328 - 335
  • [49] Clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban, an oral direct factor Xa inhibitor, in healthy Caucasian and Japanese subjects
    Kadokura, Takeshi
    Kashiwa, Makoto
    Groenendaal, Dorien
    Heeringa, Marten
    Mol, Roelof
    Verheggen, Frank
    Garcia-Hernandez, Alberto
    Onkels, Hartmut
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (08) : 431 - 441
  • [50] EVALUATION OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ALDAFERMIN IN HEALTHY ADULT MALE JAPANESE AND NON-JAPANESE SUBJECTS
    Li, Yan
    Chan, Ming Liang
    Harr, Mihoko
    Nguyen, David
    Ling, Lei
    Willett, Michael S.
    HEPATOLOGY, 2022, 76 : S756 - S756
12345